A spin-out from Duke University, predigen is a global leader in the development of host gene expression signatures for use as prognostic, diagnostic, and therapeutic monitoring tools.
We are devoted to advancing the diagnostics field in areas of high unmet need, including, but not limited to infectious disease, cardiovascular disease, autoimmune and inflammatory disease, drug response, and cancer.
Interested in learning more? Contact us

We would love to hear from you.

© 2018 by